[Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome].
Kuratsune, H, Yamaguti, K, Hattori, H et al. · Nihon rinsho. Japanese journal of clinical medicine · 1992
Quick Summary
This study examined 59 patients with ME/CFS to identify common symptoms and laboratory abnormalities. The main findings were that patients experienced prolonged fatigue after exercise, headaches, sleep problems, and mild fevers. Researchers found that ME/CFS patients had low levels of a substance called acylcarnitine in their muscles, which may help explain why their bodies struggle to produce energy and why they experience muscle pain and worsening symptoms after activity.
Why It Matters
This study provided early evidence that ME/CFS involves measurable biochemical abnormalities rather than being purely psychological, helping establish it as a biological illness. The proposed acylcarnitine deficiency mechanism offers a potential explanation for core ME/CFS symptoms like postexertional malaise and fatigue, which could guide future treatment research.
Observed Findings
Low 17-ketosteroid-sulfates/creatinine ratios in morning urine of CFS patients
Acylcarnitine deficiency detected in CFS patients
HHV-6 reactivation apparent in serologic testing
Postexertional malaise, headache, sleep disturbance, and mild fever were characteristic symptoms
Absence of retrovirus infection (HTLV-1, HTLV-2, HIV) in CFS patients
Inferred Conclusions
Acylcarnitine deficiency may induce skeletal muscle energy deficit, explaining fatigue, myalgia, weakness, and postexertional malaise in CFS
HHV-6 reactivation may play a role in CFS pathogenesis
CFS involves specific biochemical abnormalities distinguishable from possible CFS cases
CFS is a medical condition with identifiable laboratory markers rather than a psychiatric disorder
Remaining Questions
Is acylcarnitine deficiency a primary cause or secondary consequence of ME/CFS pathology?
What is the mechanistic relationship between HHV-6 reactivation and ME/CFS development and symptom severity?
What This Study Does Not Prove
This study does not prove that acylcarnitine deficiency causes ME/CFS, only that it is associated with the illness. The study cannot establish whether HHV-6 reactivation is a cause of ME/CFS or merely a consequence of immune dysfunction. Results from this Japanese population may not fully generalize to other ethnic or geographic populations.